Impact of Point-Spread Function Reconstruction on 68Ga-DOTATATE PET/CT Quantitative Imaging Parameters

被引:3
|
作者
You, Helena [1 ]
Sanli, Yasemin [1 ]
Subramaniam, Rathan M. [1 ,2 ,3 ]
机构
[1] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA
[3] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA
关键词
Ga-68-DOTATATE; neuroendocrine tumors; PET/CT; point-spread function; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; TIME-OF-FLIGHT; NEUROENDOCRINE TUMORS; F-18-FDG PET/CT; MANAGEMENT; HETEROGENEITY; DIAGNOSIS; IN-111-DTPA-OCTREOTIDE; DOSIMETRY;
D O I
10.2214/AJR.18.21067
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of our study was to investigate the impact of point-spread function (PSI) reconstruction and lesion size on Ga-68-tetraazacyclododecanetetraacetic acid-DPhel-Tyr3-octreotate (DOTATATE) PET/CT quantitative parameters. MATERIALS AND METHODS. A total of 38 patients with 42 Ga-68-DOATATE PET/CT studies and 125 lesions were included. Scans were reconstructed with and without PSF modulation. For each lesion, the maximum standardized uptake value (SUVmax) and peak standardized uptake value (SUVpeak), metabolic tumor volume (MTV), total lesion somatostatin avidity, and tumor somatostatin receptor expression heterogeneity using the AUC method were measured. Intraclass correlation coefficient (ICC) and Bland-Altman analyses were used to compare PSF and non-PSF values. A subgroup analysis was performed to determine the impact of lesion size. RESULTS. Of the 125 lesions, 51 were in the liver, 31 in lymph nodes, 17 in bone, eight in pancreas, four in lung, and 14 in other sites. The ICCs between PSF and non-PSF values were excellent for SUVmax, SUVpeak, MTV, and total lesion somatostatin avidity (ICC = 0.97-0.99), and the ICC was good for tumor somatostatin receptor expression heterogeneity (ICC = 0.81). Comparison of PSF with non-PSF values showed a bias (mean percentage change +/- SD) of 27.5% +/- 14.7% for SUVmax, 15.5% +/- 9.5% for SUVpeak, -18.6% +/- 37.6% for MTV, 0.8% +/- 28.1% for total lesion somatostatin avidity, and -7.1% +/- 11.0% for tumor somatostatin receptor expression heterogeneity. Comparison of PSF with non-PSF values for lesions less than 2 cm (n = 75) showed corresponding biases greater than those for lesions 2 cm or larger (n = 50). CONCLUSION. PSF reconstruction effected higher values for SUVmax and SUVpeak, produced decreased values for tumor somatostatin receptor expression heterogeneity, and had a variable effect on MTV and total lesion somatostatin avidity depending on lesion size.
引用
收藏
页码:683 / 688
页数:6
相关论文
共 50 条
  • [31] 68Ga-DOTATATE PET/CT in Focal Fatty Sparing of the Liver
    Hod, Nir
    Levin, Daniel
    Anconina, Reut
    Taragin, Benjamin H.
    Dudnik, Julia
    Lantsberg, Sophie
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (10) : 815 - 817
  • [32] Paraganglioma With Intracranial Invasion Demonstrated on 68Ga-DOTATATE PET/CT
    Kesim, Selin
    Filizoglu, Nuh
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (02) : e105 - e106
  • [33] Visual and whole-body quantitative analyses of 68Ga-DOTATATE PET/CT for prognosis of outcome after PRRT with 177Lu-DOTATATE
    Hotta, Masatoshi
    Sonni, Ida
    Thin, Pan
    Nguyen, Kathleen
    Gardner, Linda
    Ciuca, Liliana
    Hayrapetian, Artineh
    Lewis, Meredith
    Lubin, David
    Allen-Auerbach, Martin
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (04) : 296 - 304
  • [34] 68Ga-DOTATATE PET/CT Imaging of a Solitary Nasopharyngeal Metastasis of Merkel Cell Carcinoma
    Ding, Haoyuan
    Wang, Yudi
    He, Kaixiang
    Liu, Ya
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : 973 - 974
  • [35] A Practical Guide for the Production and PET/CT Imaging of 68Ga-DOTATATE for Neuroendocrine Tumors in Daily Clinical Practice
    Aalbersberg, Else A.
    Geluk-Jonker, Martine M.
    Young-Mylvaganan, Thirumaraichelvi
    de Wit-van der Veen, Linda J.
    Stokkel, Marcel P. M.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (146):
  • [36] Imaging Characteristics of Coexisting Primary Pulmonary Carcinoid Tumor and Multiple Myeloma on 18F-FDG and 68Ga-DOTATATE PET/CT
    Lu, Yang
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (11) : 914 - 915
  • [37] Distinct Imaging Characteristics of Different Metastases From Primary Prostate Adenocarcinoma and Rectal Carcinoid Tumor on 18F-Fluciclovine and 68Ga-DOTATATE PET/CT
    Bosserman, Andrew John
    Dai, Dong
    Lu, Yang
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : 83 - 84
  • [38] 68Ga-DOTATATE and 68Ga-Pentixafor PET/CT in a Patient with Castleman Disease of the Retroperitoneum
    Zuo, Rui
    Xu, Lu
    Pang, Hua
    DIAGNOSTICS, 2024, 14 (04)
  • [39] Intra-individual comparison of 68Ga-DOTATATE PET/CT and PET/MR
    Ahmadi, Bidakhvidi N.
    Lens, G.
    Vandecaveye, V.
    Grauwels, S.
    Deckers, W.
    Dekervel, J.
    Verslype, C.
    van Cutsem, E.
    Koole, M.
    Goffin, K.
    van Laere, K.
    Deroose, C. M.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 174 - 174
  • [40] 68Ga-DOTATATE PET/CT Findings of Cervical Esophageal Neuroendocrine Tumor
    Filizoglu, Nuh
    Ozguven, Salih
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) : E393 - E394